title: Haemolytic uraemic syndrome during treatment with ketorolac trometamol.
authors.affiliation: Institute of Medical Semeiotics, Padua University School of Medicine, Padova, Italy.
authors.forename: M L
authors.initials: ML
authors.lastname: Randi
authors.forename: T
authors.initials: T
authors.lastname: Tison
authors.forename: G
authors.initials: G
authors.lastname: Luzzatto
authors.forename: A
authors.initials: A
authors.lastname: Girolami
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D020911:Ketorolac Tromethamine; D008875:Middle Aged; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives*; D014325:Tromethamine / Q000009:adverse effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D014325:Tromethamine; D020911:Ketorolac Tromethamine; D014046:Tolmetin